BENDEKA (BENDAMUSTINE HCI) INJECTION Trademark

Trademark Overview

On Friday, November 20, 2015, a trademark application was filed for BENDEKA (BENDAMUSTINE HCI) INJECTION with the United States Patent and Trademark Office. The USPTO has given the BENDEKA (BENDAMUSTINE HCI) INJECTION trademark a serial number of 86826912. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 17, 2023. This trademark is owned by Cephalon, Inc.. The BENDEKA (BENDAMUSTINE HCI) INJECTION trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma
bendeka (bendamustine hci) injection

General Information

Serial Number86826912
Word MarkBENDEKA (BENDAMUSTINE HCI) INJECTION
Filing DateFriday, November 20, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 17, 2023
Registration Number5014704
Registration DateTuesday, August 2, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements

Description of MarkThe mark consists of the word "BENDEKA" in capital orange letters with the words "bendamustine HCI" in lower case gray letters directly underneath in parenthesis and the word "injection" in lower case gray letters directly underneath. There is a tilted triangle shape of gray, lime green and orange ribbons directly to the left of the word "BENDEKA".
Indication of Colors claimedThe color(s) orange, lime green and gray is/are claimed as a feature of the mark.
Goods and ServicesProviding an interactive website featuring information for health care professionals and patients relating to the treatment of leukemia and lymphoma
Disclaimer with Predetermined Text"BENDAMUSTINE HCI" AND "INJECTION"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 25, 2015
Primary Code044
First Use Anywhere DateWednesday, April 27, 2016
First Use In Commerce DateWednesday, April 27, 2016

Trademark Owner History

Party NameTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type27 - NOT AVAILABLE
AddressWest Chester, PA 19380
Party NameCephalon, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355
Party NameCephalon, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355
Party NameCephalon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrazer, PA 19355

Trademark Events

Event DateEvent Description
Friday, February 17, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 17, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 17, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 2, 2022TEAS SECTION 8 & 15 RECEIVED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 2, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 14, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 14, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 14, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 29, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 2, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, June 28, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 27, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 25, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 1, 2016USE AMENDMENT FILED
Saturday, June 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 1, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 3, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 2, 2016ASSIGNED TO LIE
Tuesday, December 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, December 27, 2015EXAMINER'S AMENDMENT ENTERED
Sunday, December 27, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, December 27, 2015EXAMINERS AMENDMENT E-MAILED
Sunday, December 27, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 16, 2015ASSIGNED TO EXAMINER
Thursday, November 26, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, November 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 24, 2015NEW APPLICATION ENTERED

Related Keywords

injection bendamustine bendeka relating patients treatment leukemia lymphoma professionals care website interactive featuring